66 related articles for article (PubMed ID: 1339986)
1. Preliminary findings for an inactivated African horsesickness vaccine using binary ethyleneimine.
Hassanain MM
Rev Elev Med Vet Pays Trop; 1992; 45(3-4):231-4. PubMed ID: 1339986
[TBL] [Abstract][Full Text] [Related]
2. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for African horse sickness vaccines for use in nonendemic areas.
House JA
Rev Elev Med Vet Pays Trop; 1993; 46(1-2):77-81. PubMed ID: 8134660
[TBL] [Abstract][Full Text] [Related]
4. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
5. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
von Teichman BF; Smit TK
Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
[TBL] [Abstract][Full Text] [Related]
8. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
[TBL] [Abstract][Full Text] [Related]
9. Detection of African horsesickness (AHS) in recently vaccinated horses with inactivated vaccine in Qatar.
Hassanain MM; al-Afaleq AI; Soliman IM; Abdullah SK
Rev Elev Med Vet Pays Trop; 1990; 43(1):33-5. PubMed ID: 2263741
[TBL] [Abstract][Full Text] [Related]
10. Inactivated vaccine for protection against duck virus enteritis.
Shawky SA; Sandhu TS
Avian Dis; 1997; 41(2):461-8. PubMed ID: 9201416
[TBL] [Abstract][Full Text] [Related]
11. Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine.
Aarthi D; Ananda Rao K; Robinson R; Srinivasan VA
Biologicals; 2004 Sep; 32(3):153-6. PubMed ID: 15536046
[TBL] [Abstract][Full Text] [Related]
12. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
13. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
[TBL] [Abstract][Full Text] [Related]
14. Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production.
Mondal SK; Neelima M; Seetha Rama Reddy K; Ananda Rao K; Srinivasan VA
Biologicals; 2005 Sep; 33(3):185-9. PubMed ID: 16084736
[TBL] [Abstract][Full Text] [Related]
15. Isolation and identification of African horsesickness virus from naturally infected dogs in Upper Egypt.
Salama SA; Dardiri AH; Awad FI; Soliman AM; Amin MM
Can J Comp Med; 1981 Oct; 45(4):392-6. PubMed ID: 7337871
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
Heldens JG; Pouwels HG; van Loon AA
Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
[TBL] [Abstract][Full Text] [Related]
17. [Immunisation of fancy chickens against Newcastle disease].
Freund I; Dzapo V; Vielitz E; Redmann T; Kaleta EF
Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):414-8. PubMed ID: 11721588
[TBL] [Abstract][Full Text] [Related]
18. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
[TBL] [Abstract][Full Text] [Related]
19. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
Barteling SJ; Cassim NI
Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
[TBL] [Abstract][Full Text] [Related]
20. Trials for preparation of inactivated sheep pox vaccine using binary ethyleneimine.
Awad M; Michael A; Soliman SM; Samir SS; Daoud AM
Egypt J Immunol; 2003; 10(2):67-72. PubMed ID: 15719613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
